In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Lifril Drug Master File in Korea (Lifril KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lifril. The MFDS reviews the Lifril KDMF as part of the drug registration process and uses the information provided in the Lifril KDMF to evaluate the safety and efficacy of the drug.
After submitting a Lifril KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lifril API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Lifril suppliers with KDMF on PharmaCompass.